Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00401128
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
The Cleveland Clinic 9
Testing effectiveness (Phase 2)UnknownNCT05879471
What this trial is testing

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 39
Not applicableNot Yet RecruitingNCT04670887
What this trial is testing

Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts

Who this might be right for
Cystic Renal DiseaseKidney CancerSurgery
Helsinki University Central Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Not applicableTemporarily pausedNCT06722807
What this trial is testing

ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses

Who this might be right for
Renal Cell Carcinoma (RCC)
University of Florida 59
Not applicableUnknownNCT04213664
What this trial is testing

Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.

Who this might be right for
Renal Cell CarcinomaProgressionLymphocyte Disorder+2 more
Corporacion Parc Tauli 4,666
Testing effectiveness (Phase 2)WithdrawnNCT06361810
What this trial is testing

PSMA Therapy and Immunotherapy in Kidney Cancer

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Active Not RecruitingNCT06099782
What this trial is testing

Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 147
Early research (Phase 1)Ended earlyNCT06191796
What this trial is testing

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
Exelixis 25
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Very early researchLooking for participantsNCT07645690
What this trial is testing

The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Chinese PLA General Hospital 30
Not applicableUnknownNCT06363123
What this trial is testing

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Who this might be right for
Lung CancerBreast CancerColorectal Cancer+10 more
Beijing Friendship Hospital 2,700
Testing effectiveness (Phase 2)Study completedNCT00515697
What this trial is testing

Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Eli Lilly and Company 39
Testing effectiveness (Phase 2)UnknownNCT00005038
What this trial is testing

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT00601926
What this trial is testing

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Paul Monk 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Large-scale testing (Phase 3)Active Not RecruitingNCT04810078
What this trial is testing

Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread

Who this might be right for
Clear Cell Renal Cell Carcinoma
Bristol-Myers Squibb 681
Testing effectiveness (Phase 2)UnknownNCT04534998
What this trial is testing

Robotic-assisted vs. Open Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Universitätsmedizin Mannheim 50
Large-scale testing (Phase 3)Study completedNCT00930033
What this trial is testing

Clinical Trial to Assess the Importance of Nephrectomy

Who this might be right for
Metastatic Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 452
Early research (Phase 1)Active Not RecruitingNCT06049576
What this trial is testing

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
City of Hope Medical Center 31
Next Page